首页> 外国专利> TREATMENT OF INFLAMMATORY CONDITIONS AND IMPROVEMENT OF HYGIENIC CONDITION OF THE ORAL CAVITY BY USING AGENTS CONNECTING METALS AND METHYL SULPHONYLMETHANE AS AN AMPLIFIER OF THEIR VEHICLE

TREATMENT OF INFLAMMATORY CONDITIONS AND IMPROVEMENT OF HYGIENIC CONDITION OF THE ORAL CAVITY BY USING AGENTS CONNECTING METALS AND METHYL SULPHONYLMETHANE AS AN AMPLIFIER OF THEIR VEHICLE

机译:通过使用连接金属和甲基亚磺基甲烷的助剂作为车辆的增效剂,治疗发炎状况并改善口腔的卫生状况

摘要

1. An oral composition comprising a biocompatible chelating agent at a concentration of at least 0.1% (w / w) and a permeation enhancer at an effective concentration. The composition of claim 1, wherein the carrier is at least partially aqueous. A composition according to claim 2, containing a solution. A composition according to claim 2, containing a suspension. 5. The composition of claim 2, wherein the carrier also includes a water-swellable polymer, and the composition is a hydrogel. A composition according to claim 2, in which the carrier also contains a polymer that forms a thermally dependent hydrogel, so that the composition after administration to the body forms an in situ hydrogel. The composition of claim 1, wherein the carrier is an ointment base, and the composition is an ointment. The composition of claim 1, wherein the carrier is a lotion base, and the composition is a lotion. The delivery system of a therapeutic agent for the oral cavity containing the liposome dispersion of the composition according to p. 1.10. The delivery system of a therapeutic agent according to claim 9, containing a colloidal suspension of microspheres, nanospheres, microparticles or nanoparticles containing the composition according to claim 1.11. The composition of claim 1, wherein the biocompatible chelating agent is selected from ethylenediaminetetraacetic acid (EDTA), cyclohexanediaminetetraacetic acid (CDTA), hydroxyethylethylene diamine triacetic acid (HEDTA), diethylene triamine pentaacetic acid (DPTA) dimethanopropane dimethanopropane dimethanopropane dimethanopropane dimethanopropane dimethanopropane dimethanopropane aminotrimethylene phosphonic acid (ATRA), citric acid, curcumin and their acceptable salts and combinations of these substances. 12. The composition of claim 11, wherein the biocompatible chelating agent is EDTA or its acceptable salts.
机译:1.一种口腔组合物,其包含浓度为至少0.1%(w / w)的生物相容性螯合剂和有效浓度的渗透促进剂。 2.根据权利要求1所述的组合物,其中,所述载体至少部分是水性的。 3.根据权利要求2的组合物,其包含溶液。 3.根据权利要求2的组合物,包含悬浮液。 5.权利要求2的组合物,其中所述载体还包括水溶胀性聚合物,并且所述组合物是水凝胶。 3.根据权利要求2所述的组合物,其中所述载体还包含形成热依赖性水凝胶的聚合物,使得所述组合物在施用于身体后形成原位水凝胶。 2.根据权利要求1所述的组合物,其中所述载体是软膏基质,并且所述组合物是软膏。 2.根据权利要求1所述的组合物,其中,所述载体是洗剂基质,并且所述组合物是洗剂。用于口腔的治疗剂的递送系统,其包含根据p.1的组合物的脂质体分散体。 1.10。 10.根据权利要求9所述的治疗剂的递送系统,其包含微球,纳米球,微粒或纳米颗粒的胶体悬浮液,所述胶体悬浮液包含根据权利要求1.11所述的组合物。 2.根据权利要求1所述的组合物,其中所述生物相容性螯合剂选自乙二胺四乙酸(EDTA),环己二胺四乙酸(CDTA),羟乙基乙二胺三乙酸(HEDTA),二亚乙基三胺五乙酸(DPTA)二甲基丙烷二甲基丙烷二甲基丙烷二甲基丙烷二甲基丙烷二甲基丙烷二甲基丙烷三甲基丙烷酸(ATRA),柠檬酸,姜黄素及其可接受的盐以及这些物质的组合。 12.权利要求11的组合物,其中所述生物相容性螯合剂是EDTA或其可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号